122 related articles for article (PubMed ID: 26137529)
1. SNaPshot as a Valuable Option for the Identification of Mutations in Myeloma.
Moreaux J
EBioMedicine; 2015 Jan; 2(1):13-4. PubMed ID: 26137529
[No Abstract] [Full Text] [Related]
2. Targeting BRAF in multiple myeloma.
O'Donnell E; Raje NS
Cancer Discov; 2013 Aug; 3(8):840-2. PubMed ID: 23928771
[TBL] [Abstract][Full Text] [Related]
3. Spatially divergent clonal evolution in multiple myeloma: overcoming resistance to BRAF inhibition.
Raab MS; Lehners N; Xu J; Ho AD; Schirmacher P; Goldschmidt H; Andrulis M
Blood; 2016 Apr; 127(17):2155-7. PubMed ID: 26884375
[No Abstract] [Full Text] [Related]
4. Targeting the BRAF V600E mutation in multiple myeloma.
Andrulis M; Lehners N; Capper D; Penzel R; Heining C; Huellein J; Zenz T; von Deimling A; Schirmacher P; Ho AD; Goldschmidt H; Neben K; Raab MS
Cancer Discov; 2013 Aug; 3(8):862-9. PubMed ID: 23612012
[TBL] [Abstract][Full Text] [Related]
5. Rapidly metastasizing malignant melanoma characterized by a rare BRAF mutation not responding to vemurafenib.
Starz H; Gutschi M; Welzel J; Haas C
J Dtsch Dermatol Ges; 2014 Feb; 12(2):151-4. PubMed ID: 24238398
[No Abstract] [Full Text] [Related]
6. Vemurafenib response in 2 patients with posttransplant refractory BRAF V600E-mutated multiple myeloma.
Sharman JP; Chmielecki J; Morosini D; Palmer GA; Ross JS; Stephens PJ; Stafl J; Miller VA; Ali SM
Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):e161-3. PubMed ID: 24997557
[No Abstract] [Full Text] [Related]
7. Concerns regarding BRAF testing algorithm.
Clark RR; Garioch JJ; Moncrieff MD
Br J Dermatol; 2013 Nov; 169(5):1167-8. PubMed ID: 23855527
[No Abstract] [Full Text] [Related]
8. Concerns regarding BRAF testing algorithm: reply from authors.
Gonzalez D; Fearfield L; Nathan P; Tanière P; Wallace A; Brown E; Harwood C; Marsden J; Whittaker S
Br J Dermatol; 2013 Nov; 169(5):1168-70. PubMed ID: 23855556
[No Abstract] [Full Text] [Related]
9. Vemurafenib therapy for stage IV melanoma with V600G-mutation.
Lang N; Weisser A; Enk A; Hassel JC
J Dtsch Dermatol Ges; 2013 Dec; 11(12):1198-9. PubMed ID: 24016000
[No Abstract] [Full Text] [Related]
10. Let's Not Put All Our Eggs in One Basket.
Hunter DJ; D'Agostino RB
N Engl J Med; 2015 Aug; 373(8):691-3. PubMed ID: 26287847
[No Abstract] [Full Text] [Related]
11. Vemurafenib in combination with cobimetinib in relapsed and refractory extramedullary multiple myeloma harboring the BRAF V600E mutation.
Mey UJM; Renner C; von Moos R
Hematol Oncol; 2017 Dec; 35(4):890-893. PubMed ID: 27641727
[TBL] [Abstract][Full Text] [Related]
12. Community experience of vemurafenib for BRAF(V600) melanoma.
Hersey P
Lancet Oncol; 2014 Apr; 15(4):369-70. PubMed ID: 24582506
[No Abstract] [Full Text] [Related]
13. BRAF inhibition in refractory hairy-cell leukemia.
Dietrich S; Glimm H; Andrulis M; von Kalle C; Ho AD; Zenz T
N Engl J Med; 2012 May; 366(21):2038-40. PubMed ID: 22621641
[No Abstract] [Full Text] [Related]
14. BRAF(V600) mutation levels predict response to vemurafenib in metastatic melanoma.
Lebbé C; How-Kit A; Battistella M; Sadoux A; Podgorniak MP; Sidina I; Pages C; Roux J; Porcher R; Tost J; Mourah S
Melanoma Res; 2014 Aug; 24(4):415-8. PubMed ID: 24933605
[No Abstract] [Full Text] [Related]
15. Melanoma Drug Works in Other Tumors.
Cancer Discov; 2015 Nov; 5(11):1117. PubMed ID: 26385779
[TBL] [Abstract][Full Text] [Related]
16. PLX4032 and melanoma: resistance, expectations and uncertainty.
Roukos DH
Expert Rev Anticancer Ther; 2011 Mar; 11(3):325-8. PubMed ID: 21417847
[No Abstract] [Full Text] [Related]
17. FDA approves vemurafenib for treatment of metastatic melanoma.
Oncology (Williston Park); 2011 Sep; 25(10):906. PubMed ID: 22010387
[No Abstract] [Full Text] [Related]
18. Clinical Pharmacokinetics of Vemurafenib in BRAF-Mutated Melanoma Patients.
Nijenhuis CM; Huitema AD; Blank C; Haanen JB; van Thienen JV; Rosing H; Schellens JH; Beijnen JH
J Clin Pharmacol; 2017 Jan; 57(1):125-128. PubMed ID: 27365214
[No Abstract] [Full Text] [Related]
19. Colorectal cancer: Targeting BRAF mutations equally?
Hutchinson L
Nat Rev Clin Oncol; 2016 Jan; 13(1):4. PubMed ID: 26552951
[No Abstract] [Full Text] [Related]
20. Hairy cell leukemia.
Dearden C
Best Pract Res Clin Haematol; 2015 Dec; 28(4):163-5. PubMed ID: 26614893
[No Abstract] [Full Text] [Related]
[Next] [New Search]
